All Journals > The Journal of Infectious Diseases > 1 June 2006 > US28 Gene Expression during CMV

Article Tools

Search for Related Articles

  • By Author
  • Search In

Announcements

Science Watch logo

JID Article Named "New Hot Paper" by ScienceWatch.com

Dr. Lauri Hicks' 2007 article on pneumococcal disease has been named a "hot new paper" by Thompson Reuters' ScienceWatch.com. Read a Q&A about the article with Dr. Hicks here

Press Release

Unique Collaboration Charts the Migrations of a Parasite that Affected History
Researchers Sequence Louse DNA from Mummies and Propose New Model for its Development


In the News

Featured in Grist
"Another symptom of swine flu: instant amnesia" May 11, 2009
Swine Influenza Virus: Zoonotic Potential and Vaccination Strategies for the Control of Avian and Swine Influenzas
Eileen Thacker and Bruce Janke
Read the veterinary literature on swine flu and you get a strong sense of what might be called vaccination treadmill: the hog industry is literally scrambling to generate new vaccines for the rapidly evolving flu strains that sweep through CAFOs. Writing in the Journal of Infectious Diseases [PDF] in 2008, Eileen Thacker and Bruce Janke of Iowa State University paint a stark picture: “A number of genetically diverse viruses are circulating in swine herds throughout the world and are a major cause of concern to the swine industry,” they write. “Influenza virus infections in swine and poultry are potential sources of viruses for the next pandemic among humans.”

Featured in New York Times
"Fear of a Swine Flu Epidemic in 1976 Offers Some Lessons, and Concerns, Today" May 8, 2009
Anti‐Ganglioside Antibody Induction by Swine (A/NJ/1976/H1N1) and Other Influenza Vaccines: Insights into Vaccine‐Associated Guillain‐Barré Syndrome
Irving Nachamkin, Sean V. Shadomy, Anthony P. Moran, Nancy Cox, Collette Fitzgerald, Huong Ung, Adrian T. Corcoran, John K. Iskander, Lawrence B. Schonberger, and Robert T. Chen
Irving Nachamkin, a professor of pathology and laboratory medicine at the University of Pennsylvania, examined some 1976 vaccine that had been saved by a scientist in Texas. In a paper published last year in The Journal of Infectious Diseases, he and colleagues reported that mice given the vaccine made antibodies that reacted with gangliosides, which are components of nerve cells. An antibody attack on gangliosides is part of the disease mechanism of Guillain-Barré.

Featured in AFP
"Swine flu vaccine 'could be ready soon'" May 7, 2009
A Broadly Protective Vaccine against Globally Dispersed Clade 1 and Clade 2 H5N1 Influenza Viruses
Mary A. Hoelscher, Neetu Singh, Sanjay Garg, Lakshmi Jayashankar, Vic Veguilla, Aseem Pandey, Yumi Matsuoka, Jacqueline M. Katz, Ruben Donis, Suresh K. Mittal, and Suryaprakash Sambhara
The vaccine Mittal created for the bird flu worked on three different strains isolated over a seven-year period and was described in papers for the Journal of Infectious Diseases and the journal Clinical Pharmacology and Therapeutics.

Featured in Newsweek
"The Path of a Pandemic" http://www.newsweek.com/id/195692
Swine Influenza Virus: Zoonotic Potential and Vaccination Strategies for the Control of Avian and Swine Influenzas
Eileen Thacker and Bruce Janke
Last year researchers from Iowa State University in Ames warned that pigs located in industrial-scale farms were being subjected to influenza infections from farm poultry, wild birds and their human handlers. Writing in The Journal of Infectious Diseases, Eileen Thacker and Bruce Janke said, "As a result of the constantly changing genetic makeup of individual influenza viruses in pigs, the U.S. swine industry is continually scrambling to respond to the influenza viruses circulating within individual production systems."

1 June 2006

Volume 193, Number 11
The Journal of Infectious Diseases 2006;193:1552–1556
0022-1899/2006/19311-0012$15.00
DOI: 10.1086/503779
BRIEF REPORT

Kinetics of US28 Gene Expression during Active Human Cytomegalovirus Infection in Lung‐Transplant Recipients

Jasper M. Boomker,1,3

Erik A. M. Verschuuren,2

Marja G. L. Brinker,1,3

Lou F. M. H. de Leij,1,3

T. Hauw The,2 and

Martin C. Harmsen1,3

1Department of Pathology and Laboratory Medicine, Medical Biology Section, and 2Department of Clinical Immunology, University Medical Center Groningen, and 3Groningen University Institute for Drug Exploration, University of Groningen, Groningen, The Netherlands

Targeting viral proteins early during infection may limit exacerbation of human cytomegalovirus infection. The viral chemokine‐receptor homologue US28 interferes with leukocyte trafficking and, possibly, viral replication. Because US28 molecules are abundant on the surface of infected cells, this homologue is a potential target for antiviral therapy. To assess the relationship between US28 and disease activity, we measured, by quantitative reverse‐transcription polymerase chain reaction, the levels of US28 and immediate‐early (IE) 1 gene transcripts in the blood of lung‐transplant recipients. We found that, during primary and secondary infection, the IE1 and US28 genes have early transcription kinetics and are expressed at similar levels. This may render US28 an attractive target for antiviral therapy.

Received 28 October 2005; accepted 23 December 2005; electronically published 24 April 2006.

Reprints or correspondence: Dr. M. C. Harmsen, Dept. of Pathology and Laboratory Medicine, Medical Biology Section, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands ().

Cited by

M. P. M. Stropes, W. E. Miller. (2008) Functional analysis of human cytomegalovirus pUS28 mutants in infected cells. Journal of General Virology 89:1, 97-105
Online publication date: 1-Feb-2008.
CrossRef
Atul Humar, Deepali Kumar, Michael Gray, George Moussa, Srividhya Venkataraman, Raahul Kumar, Graham A. Tipples. (2007) A Prospective Assessment of Cytomegalovirus Immune Evasion Gene Transcription Profiles in Transplant Patients With Cytomegalovirus Infection. Transplantation 83:9, 1200-1206
Online publication date: 1-Jun-2007.
CrossRef
  • Potential conflicts of interest: none reported.

    Financial support: Groningen University Institute for Drug Exploration (grant).

Close Popup